NR 508 (NR 508)
Kaplan University
Page 2 out of 23 results
Sort by
-
NR 508 | NR508 Advanced Pathophysiology- Endocrine Study guide.
- Summary • 14 pages • 2021
-
- $14.49
- + learn more
NR 508 | NR508 Advanced Pathophysiology- Endocrine Study guide.
-
NR 508 - Week 7 Exam
- Exam (elaborations) • 8 pages • 2021
-
- $12.89
- + learn more
NR 508 - Week 7 Exam /NR 508 - Week 7 Exam. 
Digoxin levels need to be monitored closely when the following medication is started: 
4. Albuterol 
Patients with pheochromocytoma should avoid which of the following classes of drugs because of the possibility of developing hypertensive crisis? 
2. Beta-2-agonists 
Harold, a 42-year-old African American, has moderate persistent asthma. Which of the following asthma medications should be used cautiously, if at all? 
2. Salmeterol, an inhaled long-act...
-
NR 508 - Week 5 Exam.
- Exam (elaborations) • 14 pages • 2021
-
- $14.99
- + learn more
NR 508 - Week 5 Exam/NR 508 - Week 5 Exam. 
Both men and women experience bone loss with aging. The bones most likely to demonstrate significant loss are: 
Bisphosphonates treat or prevent osteoporosis by:
-
NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3).
- Exam (elaborations) • 27 pages • 2021
-
- $15.49
- + learn more
NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3)/NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3). 
A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should:
-
NR 326 - Mental Health Exam 2 Review.
- Exam (elaborations) • 16 pages • 2020
-
- $15.49
- + learn more
NR 508 - Mental Health Exam 2 Review/NR 508 - Mental Health Exam 2 Review.
As you read this, a fellow student has made another $4.70
-
NR 508 - Week 5 Exam 2020.
- Exam (elaborations) • 14 pages • 2020
-
- $14.99
- + learn more
NR 508 - Week 5 Exam 2020/NR 508 - Week 5 Exam 2020.
-
NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3).
- Exam (elaborations) • 27 pages • 2020
-
- $15.49
- + learn more
NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3)/NR 508 - ADVANCED PHARM POSSIBLE MIDTERM QUESTIONS AND ANSWERS (VERSION 3).
-
NR 508 - Week 7 Exam 2020.
- Exam (elaborations) • 8 pages • 2020
-
- $12.99
- + learn more
NR 508 - Week 7 Exam 2020/NR 508 - Week 7 Exam 2020.
-
NR 508 - Week 3 Exam Study Guide (100% correct).
- Exam (elaborations) • 26 pages • 2020
-
- $15.49
- + learn more
NR 508 - Week 3 Exam Study Guide (100% correct)/NR 508 - Week 3 Exam Study Guide (100% correct).
-
NR 508 ADVANCED PHARM MIDTERM EXAM
- Exam (elaborations) • 27 pages • 2020
-
- $19.99
- + learn more
NR 508 ADVANCED PHARM MIDTERM EXAM
EXAM 3


A patient who has primary hyperlipidemia and who takes atorvastatin (Lipitor) continues to have LDL cholesterol of 140 mg/dL after 3 months of therapy. The primary care NP increases the dose from 10 mg daily to 20 mg daily. The patient reports headache and dizziness a few weeks after the dose increase. The NP should:
 
change the atorvastatin dose to 15 mg twice daily.
 
 
change the patient’s medication to cholestyramine (Questran).
 
Correct!...
How did he do that? By selling his study resources on Stuvia. Try it yourself! Discover all about earning on Stuvia